Lung Diseases Clinical Trial
Official title:
A Prospective Randomized Trial Comparing the Application of Arndt and Tappa Endobronchial Blocker During Pediatric One Lung Ventilation
This study aims to evaluate the efficacy and ease of placement of two different endobronchial blockers(Arndt and Tappa blocker) for pediatric patients undergoing thoracotomy. Time from laryngoscopy to successful insertion of the blocker by an experienced anaesthetist will be recorded and the difficulty of placement of the blocker will be assesed. We plan to evaluate the lung collapse and also observe the effect of two different bronchial blockers on patients' ventilation and oxygenation and adverse events such as desaturation, failed one lung ventilation.Our primary outcome is the time from laryngoscopy to successful insertion of the bronchial blocker by an experienced anaesthetist. Our secondary outcomes are effects of two different bronchial blockers on lung isolation score, ease of placement of the bronchial blocker, mechanical ventilation parameters (tidal volume, respiratory rate, peak airway pressure, plateau pressure, compliance), intraoperative blood gas analysis (paO2, pCO2, saO2, lac), frequency of malposition after successful blocker placement, surgical exposure and complications.
Status | Not yet recruiting |
Enrollment | 26 |
Est. completion date | October 20, 2023 |
Est. primary completion date | December 25, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Year to 18 Years |
Eligibility | Inclusion Criteria: - Pediatric patients undergoing thoracic surgery - American Society of Anesthesiology Class 1-2-3 Exclusion Criteria: - Denial of patients or parents - Coagulopathy - With preexisting cardiac dysfunction - Wtih history of renal and/or hepatic dysfunction |
Country | Name | City | State |
---|---|---|---|
Turkey | Istanbul University | Istanbul |
Lead Sponsor | Collaborator |
---|---|
Istanbul University |
Turkey,
Baek SY, Kim JH, Kim G, Choi JH, Jeong CY, Ryu KH, Park DH. Successful one-lung ventilation by blocking the right intermediate bronchus in a 7-year-old child: a case report. J Int Med Res. 2019 Jun;47(6):2740-2745. doi: 10.1177/0300060519845782. Epub 2019 May 8. — View Citation
Cay DL, Csenderits LE, Lines V, Lomaz JG, Overton JH. Selective bronchial blocking in children. Anaesth Intensive Care. 1975 May;3(2):127-30. — View Citation
Fabila TS, Menghraj SJ. One lung ventilation strategies for infants and children undergoing video assisted thoracoscopic surgery. Indian J Anaesth. 2013 Jul;57(4):339-44. doi: 10.4103/0019-5049.118539. Review. — View Citation
Wald SH, Mahajan A, Kaplan MB, Atkinson JB. Experience with the Arndt paediatric bronchial blocker. Br J Anaesth. 2005 Jan;94(1):92-4. Epub 2004 Oct 14. — View Citation
Wu C, Liang X, Liu B. Selective pulmonary lobe isolation with Arndt pediatric endobronchial blocker for an infant: A case report. Medicine (Baltimore). 2019 Dec;98(50):e18262. doi: 10.1097/MD.0000000000018262. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time from laryngoscopy to placement of the bronchial blocker | Time from laryngoscopy to correct insertion of the bronchial blocker by an experienced anaesthetist will be recorded. | Up to 30 minutes | |
Secondary | Lung collapse score | Lung collapse will be assesed at 5,10,15,and 20 minutes after pleural opening using a 10-point scale by the surgeon. 1 point refers to the inflated lung and 10 point refers to a completely collapsed lung. | Up to 30 minutes | |
Secondary | Difficulty of placement | The anaesthetist will rate the difficulty of placement of the bronchial blocker using a 5-point scale, 1 point being very easy and 5 points being impossible to insert. | Up to 30 minutes | |
Secondary | Tidal volume | Volume of gas delivered during each ventilator breath. | Up to 120 minutes | |
Secondary | Respiratory rate | Number of breaths delivered by the ventilator per minute. | Up to 120 minutes | |
Secondary | Peak airway pressure | Pressure used to deliver tidal volume by overcoming resistance in airways and lungs . | Up to 120 minutes | |
Secondary | Plateau pressure | End inspiratory pressure during a period with no gas flow in the circuit. | Up to 120 minutes | |
Secondary | Compliance | Change in volume of the lung produced by a change in pressure across the lung. | Up to 120 minutes | |
Secondary | Partial pressure of oxygen | Measurement of oxygen pressure in arterial blood. | At 15 minutes after initiation of one lung ventilation. | |
Secondary | Partial pressure of carbon dioxide | Measurement of carbon dioxide pressure in arterial blood. | At 15 minutes after initiation of one lung ventilation. | |
Secondary | Lactate | Lactate levels in arterial blood gas is used to evaluate tissue perfusion. | At 15 minutes after initiation of one lung ventilation. | |
Secondary | Frequency of malposition of the bronchial blocker | Frequency of malposition of the bronchial blocker after successful bronchial blocker placement will be recorded if the blocker displaces. | Up to the end of one lung ventilation intraoperatively. | |
Secondary | Length of intensive care unit (ICU) stay | If the patients stay in ICU postoperatively | Up to 48 hours | |
Secondary | First mobilitisition time | First mobilitisition time | Up to 24 hours | |
Secondary | Length of hospital stay | Length of hospital stay | Up to 1 week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Completed |
NCT04908397 -
Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
|
Phase 1 | |
Terminated |
NCT03309358 -
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
|
Phase 1 | |
Completed |
NCT03682354 -
ESPB Versus INB With PCIA in Video-assisted Thoracic Surgery
|
N/A | |
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
Recruiting |
NCT06004440 -
Real World Registry for Use of the Ion Endoluminal System
|
||
Completed |
NCT04874948 -
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
|
Phase 1 | |
Completed |
NCT02926768 -
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT01443845 -
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
|
Phase 4 | |
Terminated |
NCT00233207 -
IC14 Antibodies to Treat Individuals With Acute Lung Injury
|
Phase 2 | |
Completed |
NCT00281216 -
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
|
N/A | |
Completed |
NCT00269256 -
Stress, Environment, and Genetics in Urban Children With Asthma
|
N/A | |
Recruiting |
NCT00129350 -
Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
|
Phase 1 | |
Active, not recruiting |
NCT00115297 -
Montelukast for Early Life Wheezing
|
Phase 2/Phase 3 | |
Completed |
NCT00091767 -
Genetic Studies in Difficult to Treat Asthma: TENOR
|
N/A | |
Completed |
NCT00094276 -
Intervention for Improving Asthma Care for Minority Children in Head Start
|
N/A | |
Completed |
NCT00083798 -
Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland
|
N/A | |
Completed |
NCT00069823 -
Study of Acid Reflux in Asthma
|
Phase 3 | |
Completed |
NCT00233168 -
Effectiveness of Public Health Model of Latent Tuberculosis Infection Control for High-Risk Adolescents
|
N/A |